URT.WA
Price:
$38
Market Cap:
$53.57M
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Industry
Biotechnology
IPO Date
2021-10-27
Stock Exchange
WSE
Ticker
URT.WA
According to Urteste S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 53.57M. This represents a change of -44.81% compared to the average of 97.05M of the last 4 quarters.
The mean historical Enterprise Value of Urteste S.A. over the last ten years is 95.08M. The current 53.57M Enterprise Value has changed 5.53% with respect to the historical average. Over the past ten years (40 quarters), URT.WA's Enterprise Value was at its highest in in the March 2023 quarter at 168.88M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
95.08M
Median
89.95M
Minimum
58.38M
Maximum
140.43M
Discovering the peaks and valleys of Urteste S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 61.71%
Maximum Annual Enterprise Value = 140.43M
Minimum Annual Increase = -6.68%
Minimum Annual Enterprise Value = 58.38M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 133.15M | -5.18% |
| 2023 | 140.43M | 61.71% |
| 2022 | 86.84M | -6.68% |
| 2021 | 93.06M | 59.41% |
| 2020 | 58.38M | -0.43% |
The current Enterprise Value of Urteste S.A. (URT.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
120.14M
5-year avg
102.37M
10-year avg
95.08M
Urteste S.A.’s Enterprise Value is greater than Pharmena S.A. (29.79M), greater than Pure Biologics Spólka Akcyjna (42.46M), greater than Airway Medix S.A. (48.80M), less than NanoGroup S.A. (75.74M), less than BioMaxima S.A. (61.40M), greater than Genomtec S.A. (49.79M), greater than Adiuvo Investments S.A. (33.31M), less than Poltreg S.A. (96.15M), less than Molecure S.A. (104.48M), less than Mabion S.A. (108.70M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 29.79M | $29.96M | |
| 42.46M | $27.60M | |
| 48.80M | $34.74M | |
| 75.74M | $84.75M | |
| 61.40M | $46.54M | |
| 49.79M | $55.06M | |
| 33.31M | $6.98M | |
| 96.15M | $119.38M | |
| 104.48M | $121.35M | |
| 108.70M | $110.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Urteste S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Urteste S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Urteste S.A.'s Enterprise Value?
What is the highest Enterprise Value for Urteste S.A. (URT.WA)?
What is the 3-year average Enterprise Value for Urteste S.A. (URT.WA)?
What is the 5-year average Enterprise Value for Urteste S.A. (URT.WA)?
How does the current Enterprise Value for Urteste S.A. (URT.WA) compare to its historical average?